Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

KemPharm Shares Outstanding 2014-2020 | KMPH

KemPharm shares outstanding from 2014 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
KemPharm Annual Shares Outstanding
(Millions of Shares)
2019 2
2018 1
2017 1
2016 1
2015 0
2014 0
2013 0
KemPharm Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30 4
2020-06-30 4
2020-03-31 3
2019-12-31 2
2019-09-30 2
2019-06-30 2
2019-03-31 2
2018-12-31 1
2018-09-30 1
2018-06-30 1
2018-03-31 1
2017-12-31 1
2017-09-30 1
2017-06-30 1
2017-03-31 1
2016-12-31 1
2016-09-30 1
2016-06-30 1
2016-03-31 1
2015-12-31 0
2015-09-30 1
2015-06-30 1
2015-03-31 0
2014-12-31 0
2014-09-30 0
2014-06-30 0
2014-03-31 0
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.026B $0.013B
KemPharm Inc. is a specialty pharmaceutical company which is engaged in the discovery and development of new molecular entity prodrugs. Its product candidates include KP201/APAP, KP511/ER and KP606/ER for the treatment of pain; KP415 for the treatment of attention deficit hyperactivity disorder and KP303 for the treatment of central nervous system disorders, which are in preclinical trail stage. The Company through its LAT platform technology generate prodrug. KemPharm Inc. is based in CORALVILLE, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.163B 42.61
Takeda Pharmaceutical (TAK) Japan $54.543B 10.18
Astellas Pharma (ALPMY) Japan $30.831B 19.26
Merck (MKGAF) Germany $22.230B 0.00
Eisai (ESALY) Japan $22.065B 19.23
UCB SA (UCBJF) Belgium $20.802B 0.00
Catalent (CTLT) United States $19.480B 58.27
Grifols, S.A (GRFS) Spain $13.290B 15.22
Neurocrine Biosciences (NBIX) United States $10.744B 84.56
Jazz Pharmaceuticals (JAZZ) Ireland $9.236B 14.92
Ionis Pharmaceuticals (IONS) United States $8.567B 83.93
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.530B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $8.223B 0.00
United Therapeutics (UTHR) United States $7.428B 15.81
IPSEN SA ADR (IPSEY) France $7.292B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.885B 398.94
Sage Therapeutics (SAGE) United States $4.811B 0.00
ChemoCentryx (CCXI) United States $4.380B 0.00
PTC Therapeutics (PTCT) United States $4.302B 0.00
Hypermarcas (HYPMY) Brazil $4.092B 16.15
FibroGen (FGEN) United States $4.061B 0.00
Cronos Group (CRON) Canada $3.821B 0.00
Corcept Therapeutics (CORT) United States $3.251B 31.44
Pacira BioSciences (PCRX) United States $3.022B 65.61
Nektar Therapeutics (NKTR) United States $2.989B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.913B 14.87
Revolution Medicines (RVMD) United States $2.871B 0.00
Xencor (XNCR) United States $2.764B 0.00
Tilray (TLRY) Canada $2.393B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.923B 0.00
USANA Health Sciences (USNA) United States $1.801B 15.86
Translate Bio (TBIO) United States $1.674B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.643B 14.06
BioCryst Pharmaceuticals (BCRX) United States $1.615B 0.00
Heron Therapeutics (HRTX) United States $1.600B 0.00
Endo (ENDP) Ireland $1.568B 2.38
Ocular Therapeutix (OCUL) United States $1.491B 0.00
ImmunoGen (IMGN) United States $1.490B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.457B 10.13
Trillium Therapeutics (TRIL) Canada $1.351B 0.00
Indivior (INVVY) United States $1.344B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.145B 0.00
Karyopharm Therapeutics (KPTI) United States $1.108B 0.00
ORGANOGENESIS (ORGO) United States $1.077B 0.00
Radius Health (RDUS) United States $1.024B 0.00
Zogenix (ZGNX) United States $1.021B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.940B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Collegium Pharmaceutical (COLL) United States $0.817B 48.20
Aclaris Therapeutics (ACRS) United States $0.774B 0.00
Aerie Pharmaceuticals (AERI) United States $0.772B 0.00
VAXART, INC (VXRT) United States $0.762B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.757B 0.00
Acutus Medical (AFIB) United States $0.724B 0.00
Esperion Therapeutics (ESPR) United States $0.709B 0.00
Ardelyx (ARDX) United States $0.636B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.633B 0.00
Chinook Therapeutics (KDNY) United States $0.628B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.575B 0.00
Molecular Templates (MTEM) United States $0.565B 0.00
Harpoon Therapeutics (HARP) United States $0.564B 0.00
Flexion Therapeutics (FLXN) United States $0.563B 0.00
Siga Technologies (SIGA) United States $0.553B 15.52
PROFOUND MEDICL (PROF) Canada $0.518B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.494B 0.00
Jounce Therapeutics (JNCE) United States $0.478B 0.00
Sundial Growers (SNDL) Canada $0.467B 0.00
Akebia Therapeutics (AKBA) United States $0.455B 0.00
DURECT (DRRX) United States $0.451B 0.00
Summit Therapeutics (SMMT) United States $0.442B 0.00
TherapeuticsMD (TXMD) United States $0.432B 0.00
Altimmune (ALT) United States $0.427B 0.00
CASI Pharmaceuticals (CASI) United States $0.403B 0.00
Rafael Holdings (RFL) United States $0.394B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.390B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.380B 9.92
Innate Pharma SA (IPHYF) France $0.371B 0.00
MEI Pharma (MEIP) United States $0.324B 0.00
Concert Pharmaceuticals (CNCE) United States $0.322B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.317B 0.00
Menlo Therapeutics (VYNE) United States $0.314B 0.00
Alpine Immune Sciences (ALPN) United States $0.307B 0.00
Nature's Sunshine Products (NATR) United States $0.305B 19.62
Redhill Biopharma (RDHL) Israel $0.290B 0.00
KalVista Pharmaceuticals (KALV) United States $0.286B 0.00
Lannett Co Inc (LCI) United States $0.275B 7.25
Xeris Pharmaceuticals (XERS) United States $0.259B 0.00
Jaguar Animal Health (JAGX) United States $0.251B 0.00
CTI BioPharma (CTIC) United States $0.247B 0.00
Infinity Pharmaceuticals (INFI) United States $0.245B 0.00
IMV INC (IMV) Canada $0.242B 0.00
Otonomy (OTIC) United States $0.227B 0.00
Oncternal Therapeutics (ONCT) United States $0.216B 0.00
OptiNose (OPTN) United States $0.213B 0.00
IsoRay (ISR) United States $0.210B 0.00
Calithera Biosciences (CALA) United States $0.207B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.205B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.198B 0.00
Novan (NOVN) United States $0.192B 0.00
Aquestive Therapeutics (AQST) United States $0.189B 0.00
Taiwan Liposome (TLC) Taiwan $0.179B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.173B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.167B 0.00
Heat Biologics (HTBX) United States $0.162B 0.00
Onconova Therapeutics (ONTX) United States $0.154B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
Champions Oncology (CSBR) United States $0.152B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.150B 0.00
Lipocine (LPCN) United States $0.150B 0.00
MediWound (MDWD) Israel $0.138B 0.00
ProPhase Labs (PRPH) United States $0.134B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.117B 0.00
ElectroCore (ECOR) United States $0.117B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.114B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.110B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.097B 0.00
Iterum Therapeutics (ITRM) Ireland $0.096B 0.00
Recro Pharma (REPH) United States $0.087B 0.00
Hemispherx BioPharma (AIM) United States $0.087B 0.00
Natural Alternatives (NAII) United States $0.084B 162.13
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.084B 0.00
Nutriband (NTRB) United States $0.083B 0.00
SCYNEXIS (SCYX) United States $0.080B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.077B 0.00
Biomerica (BMRA) United States $0.073B 0.00
AgeX Therapeutics (AGE) United States $0.071B 0.00
Addex Therapeutics (ADXN) Switzerland $0.071B 0.00
CV Sciences (CVSI) United States $0.067B 0.00
India Globalization Capital (IGC) United States $0.065B 0.00
Vical (BBI) United States $0.065B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.060B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 24.77
Regulus Therapeutics (RGLS) United States $0.048B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.043B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Neos Therapeutics (NEOS) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 5.86
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Can-Fite Biopharma (CANF) Israel $0.031B 0.00
Midatech Pharma (MTP) United Kingdom $0.030B 0.00
Flex Pharma (SLRX) United States $0.030B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.021B 34.03
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.016B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
Shineco (TYHT) China $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00